A Randomized Comparison of Transitioning From Insulin GLargine to Insulin Degludec usING a Bridging Dose of Glargine Versus Direct Conversion, in Patients With Type 1 Diabetes Mellitus - a Pilot Study
Latest Information Update: 03 Mar 2024
Price :
$35 *
At a glance
- Drugs Insulin glargine (Primary) ; Insulin degludec
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GLIDING
- 01 Feb 2024 Status changed from active, no longer recruiting to completed.
- 26 Jun 2023 Primary endpoint has been met, (Mean change in percent time in range), as per Results presented at the 83rd Annual Scientific Sessions of the American Diabetes Association
- 26 Jun 2023 Results presented at the 83rd Annual Scientific Sessions of the American Diabetes Association